This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- SNMMI Procedure Standard/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version
- Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer
- A Novel Orally Active Inverse Agonist of Estrogen-related Receptor Gamma (ERR{gamma}), DN200434, A Booster of NIS in Anaplastic Thyroid Cancer
- IMAGING IN ENDOCRINOLOGY: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up
- Clinical Utility of 18F-FDG PET/CT Concurrent with 131I Therapy in Intermediate-to-High-Risk Patients with Differentiated Thyroid Cancer: Dual-Center Experience with 286 Patients
- The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery
- The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Thyroid Neoplasms
- Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?
- BRAF in primary and recurrent papillary thyroid cancers: the relationship with 131I and 2-[18F]fluoro-2-deoxy-D-glucose uptake ability
- NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types
- The Role of MR Imaging in Detecting Nodal Disease in Thyroidectomy Patients with Rising Thyroglobulin Levels
- 131I SPECT/CT in the Follow-up of Differentiated Thyroid Carcinoma: Incremental Value Versus Planar Imaging
- BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer
- 18F-FDG PET/CT in Patients with Suspected Recurrent or Metastatic Well-Differentiated Thyroid Cancer
- Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management
- PET in the follow-up of differentiated thyroid cancer
- Recombinant TSH-Stimulated, Radioguided Differentiated Thyroid Carcinoma Surgery
- Value of Recombinant Human Thyrotropin in High-Dose Radioiodine Therapy: A Case Report
- 18F-FDG PET Detection of Lymph Node Metastases in Medullary Thyroid Carcinoma
- Clinical Impact of 18F-FDG PET in Thyroid Carcinoma Patients with Elevated Thyroglobulin Levels and Negative 131I Scanning Results After Therapy
- A Tabulated Summary of the FDG PET Literature
- Comparison of 18F-FDG, 131I-Na, and 201Tl in Diagnosis of Recurrent or Metastatic Thyroid Carcinoma
- Influence of Thyroid-Stimulating Hormone Levels on Uptake of FDG in Recurrent and Metastatic Differentiated Thyroid Carcinoma
- FDG PET in Thyroid Cancer: Thyroxine or Not?